A bill in Congress would require warning labels on makeup marketed to children following recent recalls.
National cosmetics and accessories retailer Clair’s APO, +2.54% and makeup company Beauty Plus Global issued recalls last week after the FDA found the cancer-causing toxin in some products.
Some members of Congress want to make it harder for makeup companies to cover up contaminated children’s cosmetics. Rep. Debbie Dingell, a Democrat from Michigan, introduced a bill in March that would require warning labels on makeup marketed to children that could contain asbestos. In March, J&J was ordered to pay $29 million to an Oakland woman who claimed its baby powder gave her terminal cancer. Johnson & Johnson JNJ, +1.37% has faced at least 13,000 lawsuits around the country claiming its Johnson’s Baby Powder and other talc products caused ovarian cancer and mesothelioma. The company received subpoenas from the U.S.
The FDA currently doesn’t have the authority to recall cosmetics products The asbestos found in makeup products sold by Claire’s and Justice highlighted the relatively weak regulations in the U.S. around personal care products including cosmetics, soaps and shampoos, consumer safety advocates say. In other instances, companies have opted to disregard the FDA’s requests entirely. The FDA issued a “safety alert” in 2011 that Brazilian Blowout, a hair-smoothing treatment, contained formaldehyde despite labels that claimed the opposite was true. An investigation conducted by ABC News months later found that salons were still using the product, and some hair stylists were not even aware that the product contained formaldehyde, a known carcinogen.
There is no safe level of asbestos exposure, according to the federal government. Currently, no beauty products except for color additives require FDA approval before being sold. Altogether, the U.S. only bans 12 chemicals or other harmful substances from being used in personal care products –– asbestos and formaldehyde are not on that list. Comparatively, Europe bans thousands of substances.
इंडिया ताज़ा खबर, इंडिया मुख्य बातें
Similar News:आप इससे मिलती-जुलती खबरें भी पढ़ सकते हैं जिन्हें हमने अन्य समाचार स्रोतों से एकत्र किया है।
FDA approves Lilly's migraine drug as first cluster headache treatmentClinical trials showed that a one-month injection of Emgality, a migraine drug, significantly reduced the frequency of cluster headaches.
और पढो »
FDA: 'Influencers' promoted vaping without suitable warningsU.S. regulators moved to discipline vaping companies for inappropriately promoting their flavored nicotine formulas through so-called influencers on Facebook, Twitter and other social media sites. The Food and Drug Administration sent warning letters Friday to four companies that used paid social media
और पढो »
FDA calls out e-cig companies using social media 'influencers' to market productsThe federal government on Friday issued formal warnings to companies that use social media “influencers” to promote fruit flavored e-cigarette or “vape” products.
और पढो »
FDA says influencers on social media promoted vaping without proper warningsThe FDA sent warning letters to four companies that used paid social media influencers to pitch nicotine products in fruit and other flavors.
और पढो »
FDA kicks off review of CBD with 140 people scheduled to testify at first public hearing FridayThe FDA is took its first big step toward deciding whether companies can add CBD to food, beverages and dietary supplements last week.
और पढो »
The ingredient is supposed to help memory, but the FDA says it's not as safe as it's billed to beThink twice about trying this.
और पढो »